bluebird bio Inc (BLUE)
0.9125
-0.01
(-1.13%)
USD |
NASDAQ |
Apr 25, 16:00
0.9125
0.00 (0.00%)
After-Hours: 06:15
bluebird bio Cash and Short Term Investments (Quarterly): 174.29M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 174.29M |
| June 30, 2023 | 245.30M |
| March 31, 2023 | 318.26M |
| December 31, 2022 | 180.33M |
| September 30, 2022 | 139.63M |
| June 30, 2022 | 132.51M |
| March 31, 2022 | 211.59M |
| December 31, 2021 | 299.50M |
| September 30, 2021 | 777.60M |
| June 30, 2021 | 839.70M |
| March 31, 2021 | 1.012B |
| December 31, 2020 | 680.23M |
| September 30, 2020 | 1.230B |
| June 30, 2020 | 1.549B |
| March 31, 2020 | 910.68M |
| December 31, 2019 | 1.106B |
| September 30, 2019 | 1.180B |
| June 30, 2019 | 1.254B |
| March 31, 2019 | 1.322B |
| December 31, 2018 | 1.385B |
| September 30, 2018 | 1.695B |
| June 30, 2018 | 1.077B |
| Date | Value |
|---|---|
| March 31, 2018 | 1.122B |
| December 31, 2017 | 1.290B |
| September 30, 2017 | 728.77M |
| June 30, 2017 | 1.095B |
| March 31, 2017 | 634.07M |
| December 31, 2016 | 704.38M |
| September 30, 2016 | 600.96M |
| June 30, 2016 | 575.80M |
| March 31, 2016 | 553.10M |
| December 31, 2015 | 517.95M |
| September 30, 2015 | 707.46M |
| June 30, 2015 | 810.51M |
| March 31, 2015 | 334.88M |
| December 31, 2014 | 473.56M |
| September 30, 2014 | 215.37M |
| June 30, 2014 | 175.71M |
| March 31, 2014 | 192.50M |
| December 31, 2013 | 206.28M |
| September 30, 2013 | 216.79M |
| June 30, 2013 | 228.85M |
| March 31, 2013 | 131.84M |
| December 31, 2012 | 67.01M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
132.51M
Minimum
Jun 2022
1.549B
Maximum
Jun 2020
680.11M
Average
728.91M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Novavax Inc | 568.50M |
| Motus GI Holdings Inc | 4.958M |
| Tivic Health Systems Inc | 3.395M |
| Vertex Pharmaceuticals Inc | 11.22B |
| AIM ImmunoTech Inc | 13.07M |